These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
395 related articles for article (PubMed ID: 28666669)
1. Medical Treatment of Nocturia in Men with Lower Urinary Tract Symptoms: Systematic Review by the European Association of Urology Guidelines Panel for Male Lower Urinary Tract Symptoms. Sakalis VI; Karavitakis M; Bedretdinova D; Bach T; Bosch JLHR; Gacci M; Gratzke C; Herrmann TR; Madersbacher S; Mamoulakis C; Tikkinen KAO; Gravas S; Drake MJ Eur Urol; 2017 Nov; 72(5):757-769. PubMed ID: 28666669 [TBL] [Abstract][Full Text] [Related]
2. EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Oelke M; Bachmann A; Descazeaud A; Emberton M; Gravas S; Michel MC; N'dow J; Nordling J; de la Rosette JJ; Eur Urol; 2013 Jul; 64(1):118-40. PubMed ID: 23541338 [TBL] [Abstract][Full Text] [Related]
3. Desmopressin add-on therapy for refractory nocturia in men receiving α-blockers for lower urinary tract symptoms. Bae WJ; Bae JH; Kim SW; Chung BH; Kim JH; Kim CS; Lee HM; Lee KS; Yoo TK; Kim SI; Byun SS; Lee JY J Urol; 2013 Jul; 190(1):180-6. PubMed ID: 23357213 [TBL] [Abstract][Full Text] [Related]
4. The evaluation of nocturia in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia and the analysis of the curative effect after medical or placebo therapy for nocturia: a randomized placebo-controlled study. Xue Z; Lin Y; Jiang Y; Wei N; Bi J BMC Urol; 2018 Dec; 18(1):115. PubMed ID: 30545338 [TBL] [Abstract][Full Text] [Related]
5. Current medical treatment of lower urinary tract symptoms/BPH: do we have a standard? Silva J; Silva CM; Cruz F Curr Opin Urol; 2014 Jan; 24(1):21-8. PubMed ID: 24231531 [TBL] [Abstract][Full Text] [Related]
6. A contemporary assessment of nocturia: definition, epidemiology, pathophysiology, and management--a systematic review and meta-analysis. Cornu JN; Abrams P; Chapple CR; Dmochowski RR; Lemack GE; Michel MC; Tubaro A; Madersbacher S Eur Urol; 2012 Nov; 62(5):877-90. PubMed ID: 22840350 [TBL] [Abstract][Full Text] [Related]
7. Twelve-week, prospective, open-label, randomized trial on the effects of an anticholinergic agent or antidiuretic agent as add-on therapy to an alpha-blocker for lower urinary tract symptoms. Shin YS; Zhang LT; Zhao C; Kim YG; Park JK Clin Interv Aging; 2014; 9():1021-30. PubMed ID: 25031529 [TBL] [Abstract][Full Text] [Related]
8. Systematic Review of Combination Drug Therapy for Non-neurogenic Lower Urinary Tract Symptoms. Serati M; Andersson KE; Dmochowski R; Agrò EF; Heesakkers J; Iacovelli V; Novara G; Khullar V; Chapple C Eur Urol; 2019 Jan; 75(1):129-168. PubMed ID: 30293906 [TBL] [Abstract][Full Text] [Related]
9. Impact of desmopressin on nocturia due to nocturnal polyuria in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH). Berges R; Höfner K; Gedamke M; Oelke M World J Urol; 2014 Oct; 32(5):1163-70. PubMed ID: 25135845 [TBL] [Abstract][Full Text] [Related]
10. Incidence of Nocturia in Men with Lower Urinary Tract Symptoms Associated with Benign Prostatic Enlargement and Outcomes After Medical Treatment: Results from the Evolution European Association of Urology Research Foundation Prospective Multinational Registry. Malde S; Patel A; Martínez-Piñeiro L; de la Taille A; Bjartell A; Tubaro A; Witjes W; Caris C Eur Urol Focus; 2021 Jan; 7(1):178-185. PubMed ID: 31345783 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of solifenacin plus tamsulosin OCAS in men with voiding and storage lower urinary tract symptoms: results from a phase 2, dose-finding study (SATURN). Van Kerrebroeck P; Haab F; Angulo JC; Vik V; Katona F; Garcia-Hernandez A; Klaver M; Traudtner K; Oelke M Eur Urol; 2013 Sep; 64(3):398-407. PubMed ID: 23537687 [TBL] [Abstract][Full Text] [Related]
13. Male patients with a higher frequency of nocturnal urinary episodes are more likely to benefit from alpha-blocker therapy for bothersome nocturia. Lee CL; Kuo HC Low Urin Tract Symptoms; 2019 Apr; 11(2):O174-O179. PubMed ID: 30548822 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and Safety of Desmopressin Add-On Therapy for Men with Persistent Nocturia on α-Blocker Monotherapy for Lower Urinary Tract Symptoms: A Randomized, Double-Blind, Placebo Controlled Study. Kim JC; Cho KJ; Lee JG; Seo JT; Kim DY; Oh SJ; Lee KS; Choo MS; Lee JZ J Urol; 2017 Feb; 197(2):459-464. PubMed ID: 27622611 [TBL] [Abstract][Full Text] [Related]
15. Long-term safety and efficacy of single-tablet combinations of solifenacin and tamsulosin oral controlled absorption system in men with storage and voiding lower urinary tract symptoms: results from the NEPTUNE Study and NEPTUNE II open-label extension. Drake MJ; Chapple C; Sokol R; Oelke M; Traudtner K; Klaver M; Drogendijk T; Van Kerrebroeck P; Eur Urol; 2015 Feb; 67(2):262-70. PubMed ID: 25070148 [TBL] [Abstract][Full Text] [Related]
16. Tadalafil - a therapeutic option in the management of BPH-LUTS. Carson CC; Rosenberg M; Kissel J; Wong DG Int J Clin Pract; 2014 Jan; 68(1):94-103. PubMed ID: 24341303 [TBL] [Abstract][Full Text] [Related]
17. EAU Guidelines on the Assessment of Non-neurogenic Male Lower Urinary Tract Symptoms including Benign Prostatic Obstruction. Gratzke C; Bachmann A; Descazeaud A; Drake MJ; Madersbacher S; Mamoulakis C; Oelke M; Tikkinen KAO; Gravas S Eur Urol; 2015 Jun; 67(6):1099-1109. PubMed ID: 25613154 [TBL] [Abstract][Full Text] [Related]
18. Lower urinary tract symptom: still too much focus on the prostate? Warren K; Burden H; Abrams P Curr Opin Urol; 2014 Jan; 24(1):3-9. PubMed ID: 24280652 [TBL] [Abstract][Full Text] [Related]
19. [Nocturia in men with benign prostatic hyperplasia]. Oelke M; Fangmeyer B; Zinke J; Witt JH Aktuelle Urol; 2018 Aug; 49(4):319-327. PubMed ID: 30086589 [TBL] [Abstract][Full Text] [Related]